OA10144A - Ranitidine compositions - Google Patents

Ranitidine compositions Download PDF

Info

Publication number
OA10144A
OA10144A OA60638A OA60638A OA10144A OA 10144 A OA10144 A OA 10144A OA 60638 A OA60638 A OA 60638A OA 60638 A OA60638 A OA 60638A OA 10144 A OA10144 A OA 10144A
Authority
OA
OAPI
Prior art keywords
ranitidine
tablet
chewable
daims
tablet according
Prior art date
Application number
OA60638A
Other languages
English (en)
Inventor
Alan Bye
Jill Evans
Paul Derrick Huckle
Laurence Francis Lacey
Peter John Rue
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of OA10144A publication Critical patent/OA10144A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
OA60638A 1992-10-13 1995-04-11 Ranitidine compositions OA10144A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929221414A GB9221414D0 (en) 1992-10-13 1992-10-13 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
OA10144A true OA10144A (en) 1996-12-18

Family

ID=10723323

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60638A OA10144A (en) 1992-10-13 1995-04-11 Ranitidine compositions

Country Status (25)

Country Link
US (1) US5593685A (zh)
EP (2) EP0664697B1 (zh)
JP (1) JP2918691B2 (zh)
KR (1) KR950703327A (zh)
AT (1) ATE166572T1 (zh)
AU (1) AU676690B2 (zh)
BG (1) BG99567A (zh)
CA (1) CA2147000A1 (zh)
CZ (1) CZ94495A3 (zh)
DE (1) DE69318844T2 (zh)
ES (1) ES2117718T3 (zh)
GB (1) GB9221414D0 (zh)
HU (2) HUT72497A (zh)
IL (1) IL107255A (zh)
MX (1) MX9306333A (zh)
NO (1) NO951432L (zh)
NZ (1) NZ256681A (zh)
OA (1) OA10144A (zh)
PH (1) PH31433A (zh)
PL (1) PL174359B1 (zh)
SG (1) SG49850A1 (zh)
SK (1) SK48395A3 (zh)
TW (1) TW271405B (zh)
WO (1) WO1994008560A1 (zh)
ZA (1) ZA937544B (zh)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
AU7468096A (en) * 1995-10-30 1997-05-22 Warner-Lambert Company Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils
DE19639343C2 (de) * 1996-09-25 1998-10-08 Suedzucker Ag Komprimate, enthaltend ein Süßungsmittelgemisch
GB9715423D0 (en) 1997-07-23 1997-09-24 Glaxo Group Ltd Aqueous compositions
US6086920A (en) * 1998-08-12 2000-07-11 Fuisz Technologies Ltd. Disintegratable microspheres
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US7163705B2 (en) * 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US20020159956A1 (en) * 1999-04-06 2002-10-31 Ream Ronald L. Over-coated chewing gum formulations
US7935362B2 (en) * 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
US6491540B1 (en) * 1999-09-20 2002-12-10 Jack Barreca Center-filled supplement gum
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US7115288B2 (en) * 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
JP5412966B2 (ja) * 2009-06-08 2014-02-12 ライオン株式会社 粒状製剤
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0349103B1 (en) * 1988-05-04 1992-11-25 Smith Kline & French Laboratories Limited Chewable tablet
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2052679C (en) * 1990-08-30 1997-12-02 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
DE69211688T2 (de) * 1991-04-04 1997-02-06 Procter & Gamble Kaubare antacida
BR9205827A (pt) * 1991-04-04 1994-06-28 Procter & Gamble Composições farmacêuticas ingeriveis para tratamento de distúrbios do trato gastrintestinal superior
DK0587744T3 (da) * 1991-05-28 2003-10-20 Mcneil Ppc Inc Tygbar sammensætning til frigørelse af et lægemiddel
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
CA2079934C (en) * 1991-10-15 2002-09-03 Edward J. Roche Taste mask coatings for preparing chewable pharmaceutical tablets
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
NO951432D0 (no) 1995-04-12
JP2918691B2 (ja) 1999-07-12
SK48395A3 (en) 1995-11-08
IL107255A0 (en) 1994-01-25
JPH08502272A (ja) 1996-03-12
US5593685A (en) 1997-01-14
MX9306333A (es) 1995-01-31
TW271405B (zh) 1996-03-01
SG49850A1 (en) 1998-06-15
EP0664697B1 (en) 1998-05-27
ES2117718T3 (es) 1998-08-16
BG99567A (en) 1995-12-29
EP0788789A1 (en) 1997-08-13
NO951432L (no) 1995-05-12
NZ256681A (en) 1997-10-24
ZA937544B (en) 1994-04-21
HUT72497A (en) 1996-05-28
PH31433A (en) 1998-11-03
AU676690B2 (en) 1997-03-20
GB9221414D0 (en) 1992-11-25
EP0664697A1 (en) 1995-08-02
WO1994008560A1 (en) 1994-04-28
DE69318844T2 (de) 1998-10-15
AU5143493A (en) 1994-05-09
HU211847A9 (en) 1995-12-28
HU9501053D0 (en) 1995-06-28
ATE166572T1 (de) 1998-06-15
DE69318844D1 (de) 1998-07-02
IL107255A (en) 1998-07-15
CZ94495A3 (en) 1995-10-18
CA2147000A1 (en) 1994-04-28
PL308356A1 (en) 1995-07-24
PL174359B1 (pl) 1998-07-31
KR950703327A (ko) 1995-09-20

Similar Documents

Publication Publication Date Title
US5593685A (en) Ranitidine compositions
US5102665A (en) Pharmaceutical compositions
EP0891776B1 (en) Granular composition comprising simethicone and granular anhydrous calcium phosphate
US5629013A (en) Chewable calcium carbonate antacid tablet compositions
AU681672B2 (en) Preparations containing silicon dioxide to improve the taste thereof
KR100238565B1 (ko) 상부 위장관 통증을 치료하기 위한 섭취가능한 약학적 조성물
WO1997021424A1 (en) Chewing gum containing ranitidine
US6793935B2 (en) Mineral supplement
WO1995016446A1 (en) Ranitidine compositions
EP0777470A1 (en) Use of paracellular absorption enhancers such as glucose for enhancing the absorption of histamine h2-antagonists
US6265449B1 (en) Aqueous compositions comprising ranitidine and LCMT sucrose
AU690664B2 (en) Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion
IE914482A1 (en) Pharmaceutical compositions
US20100272781A1 (en) Sugar Free Chewable Tablets